Skip to main navigation Skip to search Skip to main content

A double-blind, placebo-controlled, randomized study to evaluate the safety and therapeutic effects of sapropterin dihydrochloride on neuropsychiatric symptoms in subjects with phenylketonuria

Project: Research

Project Details

StatusFinished
Effective start/end date02/15/1202/15/15

Funding

  • BioMarin Pharmaceutical Incorporated: $97,481.08